Skip to main content

Prediabetes clinical trials at University of California Health

3 in progress, 1 open to eligible people

Showing trials for
  • Investigation of Cinnamon Spice on Glucose Tolerance in Subjects With Pre-diabetes

    open to eligible people ages 20 years and up

    This study aims to determine whether the effectiveness of cinnamon spice capsules vs. placebo capsules on glucose tolerance in prediabetic subjects who are overweight or obese.

    at UCLA

  • ADRB3 Signaling Pathway in Human Adipose Tissue

    Sorry, not yet accepting patients

    This study will examine the gene expression of the adrenergic Beta-3 receptor (ADRB3) regulation in human subcutaneous adipose tissue before and after treatment with mirabegron, an ADRB3 agonist. Gene expression will be compared across two groups, lean and obese participants. There will be a total of three study visits: Screening/Eligibility, Pre-Dose Adipose Tissue Biopsy and Post-Dose Adipose Tissue Biopsy. Participants will be given a single dose of 100mg oral mirabegron on the day of the Post-Dose Adipose Tissue Biopsy.The trial design is a single-center, phase 1, open-label, exploratory study to examine the adipocyte gene expression in adults treated with 1 dose of 100mg oral mirabegron.

    at UCSD

  • Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

    Sorry, not yet accepting patients

    This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in patients who have pre-diabetes and heart or blood vessel problems.

    at UCLA UCSD

Our lead scientists for Prediabetes research studies include .

Last updated: